These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 7700458)

  • 1. Future research in Alzheimer's disease using imaging techniques.
    Budinger TF
    Neurobiol Aging; 1994; 15 Suppl 2():S41-8. PubMed ID: 7700458
    [No Abstract]   [Full Text] [Related]  

  • 2. Statistical brain mapping of 18F-FDG PET in Alzheimer's disease: validation of anatomic standardization for atrophied brains.
    Ishii K; Willoch F; Minoshima S; Drzezga A; Ficaro EP; Cross DJ; Kuhl DE; Schwaiger M
    J Nucl Med; 2001 Apr; 42(4):548-57. PubMed ID: 11337540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural imaging in the clinical diagnosis of Alzheimer's disease: problems and tools.
    Frisoni GB
    J Neurol Neurosurg Psychiatry; 2001 Jun; 70(6):711-8. PubMed ID: 11384998
    [No Abstract]   [Full Text] [Related]  

  • 4. A novel approach to brain connectivity reveals early structural changes in Alzheimer's disease.
    La Rocca M; Amoroso N; Monaco A; Bellotti R; Tangaro S
    Physiol Meas; 2018 Jul; 39(7):074005. PubMed ID: 29943735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multimodality Bayesian algorithm for image reconstruction in positron emission tomography: a tissue composition model.
    Sastry S; Carson RE
    IEEE Trans Med Imaging; 1997 Dec; 16(6):750-61. PubMed ID: 9533576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MR and PET vie in diagnosis of Alzheimer's disease.
    Lowers J
    Diagn Imaging (San Franc); 2000 Nov; 22(11):113-6. PubMed ID: 11148954
    [No Abstract]   [Full Text] [Related]  

  • 7. Inflammation and Alzheimer's disease.
    Jones RW
    Lancet; 2001 Aug; 358(9280):436-7. PubMed ID: 11513903
    [No Abstract]   [Full Text] [Related]  

  • 8. Shape-Attributes of Brain Structures as Biomarkers for Alzheimer's Disease.
    Glozman T; Solomon J; Pestilli F; Guibas L;
    J Alzheimers Dis; 2017; 56(1):287-295. PubMed ID: 27911322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroimaging in Alzheimer's disease.
    Albert MS; Lafleche G
    Psychiatr Clin North Am; 1991 Jun; 14(2):443-59. PubMed ID: 2062727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo detection of microstructural correlates of brain pathology in preclinical and early Alzheimer Disease with magnetic resonance imaging.
    Zhao Y; Raichle ME; Wen J; Benzinger TL; Fagan AM; Hassenstab J; Vlassenko AG; Luo J; Cairns NJ; Christensen JJ; Morris JC; Yablonskiy DA
    Neuroimage; 2017 Mar; 148():296-304. PubMed ID: 27989773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Partial volume correction for PET quantification and its impact on brain network in Alzheimer's disease.
    Yang J; Hu C; Guo N; Dutta J; Vaina LM; Johnson KA; Sepulcre J; Fakhri GE; Li Q
    Sci Rep; 2017 Oct; 7(1):13035. PubMed ID: 29026139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preliminary results from an MRI/CT-based database for vascular dementia and Alzheimer's disease.
    Scheltens P; Kittner B
    Ann N Y Acad Sci; 2000 Apr; 903():542-6. PubMed ID: 10818550
    [No Abstract]   [Full Text] [Related]  

  • 13. In vivo amyloid imaging in Alzheimer's disease.
    Sair HI; Doraiswamy PM; Petrella JR
    Neuroradiology; 2004 Feb; 46(2):93-104. PubMed ID: 14740203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerebrospinal Fluid Biomarkers are Differentially Related to Structural and Functional Changes in Dementia of the Alzheimer's Type.
    Malpas CB; Saling MM; Velakoulis D; Desmond P; Hicks RJ; Zetterberg H; Blennow K; O'Brien TJ
    J Alzheimers Dis; 2018; 62(1):417-427. PubMed ID: 29439322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Alzheimer's syndrome--the history of a disease and the role of modern diagnostic radiology].
    Essig M; Reith W
    Radiologe; 2003 Jul; 43(7):511-2. PubMed ID: 12962082
    [No Abstract]   [Full Text] [Related]  

  • 16. Validation of an Magnetic Resonance Imaging Acquisition and Review Protocol for Alzheimer's Disease and Related Disorders.
    Asselin A; Potvin O; Bouchard LO; Brisson M; Duchesne S
    Can Assoc Radiol J; 2019 May; 70(2):172-180. PubMed ID: 30894287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective interest of molecular neuroimaging in Alzheimer's disease.
    Guedj E
    Rev Neurol (Paris); 2013 Jan; 169(1):9-13. PubMed ID: 22682055
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of imaging modalities, brain atlases and feature selection on prediction of Alzheimer's disease.
    Ota K; Oishi N; Ito K; Fukuyama H; ;
    J Neurosci Methods; 2015 Dec; 256():168-83. PubMed ID: 26318777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of structural imaging to study the progression of Alzheimer's disease.
    Smith AD; Jobst KA
    Br Med Bull; 1996 Jul; 52(3):575-86. PubMed ID: 8949258
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel method and software for automatically classifying Alzheimer's disease patients by magnetic resonance imaging analysis.
    Previtali F; Bertolazzi P; Felici G; Weitschek E
    Comput Methods Programs Biomed; 2017 May; 143():89-95. PubMed ID: 28391822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.